Information boursière


Stock price



Stock MarketEuronext Paris – Eurolist (compartiment B)
Reuters / BloombergTRNG.PA / TNG.FP
ISIN CodeFR0005175080
Total number of shares outstanding100,852,742
Initial Public Offering (IPO)March 26, 1998
Local Sector IndexNext Biotech / CAC Mid 100
Financial Year EndsDecember 31
Cantor FitzgeraldBrandon 212-294-8081
Intron HealthNaresh 207 375 9143
Invest SecuritiesJamila El (0)1 44 88 88 09
Kempen & Co.Suzanne van (0)20 348 8484
Oddo BHFMartial (0)1 44 51 85 00

Any opinions, forecasts, estimates, projections or predictions regarding Transgene’s performance made by the analysts are theirs alone and do not necessarily represent the opinions, forecasts, estimates, projections or predictions of Transgene or its management. By providing the names of the analysts or certain information from them, Transgene does not imply its endorsement of or concurrence with their reports, conclusions or recommendations. Transgene assumes no liability for the accuracy of such information and undertakes no obligation to update it.